Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins by �뾼吏��썝
Calsyntenins Function as Synaptogenic Adhesion Molecules in 
Concert with Neurexins
Ji Won Um1, Gopal Pramanik2,3, Ji Seung Ko1, Min-Young Song4, Dongmin Lee5, Hyun 
Kim5, Kang-Sik Park4, Thomas C. Südhof6, Katsuhiko Tabuchi2,3,7, and Jaewon Ko1,#
1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, 
Seoul 120-749, Korea
2Dept. of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto 
390-8621, Japan
3Division of Cerebral Structure, Dept. of Cerebral Research, National Institute for Physiological 
Sciences, Okazaki 444-8787, Japan
4Department of Physiology and Neuroscience, Kyung Hee University School of Medicine, Seoul 
130-701, Korea
5Department of Anatomy and Neuroscience, Korea 21 Biomedical Science, College of Medicine, 
Korea University, 126-1, 5-ka, Anam-dong, Seongbuk-gu, Seoul 136-705, Korea
6Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, 
Stanford University School of Medicine, Stanford, CA 94305, USA
7PRESTO, Japan Science and Technology Agency (JST), Kawaguchi 332-0012, Japan
SUMMARY
Multiple synaptic adhesion molecules govern synapse formation. Here, we propose calsyntenin-3/
alcadein-β as a synapse organizer that specifically induces presynaptic differentiation in 
heterologous synapse-formation assays. Calsyntenin-3 (CST-3) was highly expressed during 
various postnatal periods of mouse brain development. The simultaneous knockdown of all three 
CSTs, but not CST-3 alone, decreased inhibitory, but not excitatory, synapse densities in cultured 
hippocampal neurons. Moreover, the knockdown of CSTs specifically reduced inhibitory synaptic 
transmission in vitro and in vivo. Remarkably, the loss of CSTs induced a concomitant decrease in 
neuron soma size in a non-cell-autonomous manner. Furthermore, α-neurexins (α-Nrxs) were 
affinity-purified as components of a CST-3 complex involved in CST-3-mediated presynaptic 
differentiation. However, CST-3 did not directly bind to Nrxs. Viewed together, these data suggest 
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that the three CSTs redundantly regulate inhibitory synapse formation, inhibitory synapse 
function, and neuron development in concert with Nrxs.
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INTRODUCTION
Synaptic cell adhesion molecules (CAMs) are major synapse organizers that initiate the cell 
type-specific formation of nascent synaptic contacts and recruit the pre- and postsynaptic 
protein complexes required for proper synaptic signaling (Missler et al., 2012). The list of 
synaptic CAMs has rapidly grown, largely reflecting the development of the heterologous 
synapse formation assay (Biederer and Scheiffele, 2007). Neuroligins (NLs), SynCAMs, 
Netrin-G ligands (NGLs), SALM3 and SALM5, Leucine-rich repeat transmembrane 
proteins (LRRTMs), and Slit- and Trk-like (Slitrks) proteins are among the synaptogenic 
CAMs with established synaptic functions (Missler et al., 2012; Sudhof, 2008; Um and Ko, 
2013). However, considering the number of neuronal synapses and neural circuits in the 
brain, it is reasonable to propose that additional synaptogenic CAMs remain undefined.
Calsyntenins (CSTs), called alcadeins, are members of the cadherin superfamily (Araki et 
al., 2003; Vogt et al., 2001). Originally identified from spinal cord neurons (Vogt et al., 
2001), CSTs are type I transmembrane proteins with extracellular domains containing two 
cadherin repeats and an LNS (laminin-α, neurexin, and sex hormone-binding globulin) 
domain. These proteins comprise three members: CST-1 (alcadein-α), CST-2 (alcadein-γ), 
and CST-3 (alcadein-β), and a single ortholog has also been identified in Caenorhabditis 
elegans (CASY-1 or CDH11) and Drosophila melanogaster (Cals) (Ikeda et al., 2008; 
Pettitt, 2005). CSTs are widely expressed in the central nervous system (Hintsch et al., 2002; 
Vogt et al., 2001). CST-1 is primarily expressed in the postsynaptic membranes of 
pyramidal neurons, whereas CST-2 and -3 are expressed in inhibitory neurons (Hintsch et 
al., 2002). Interestingly, CASY-1 is essential for chemotaxis-associated learning (Hoerndli 
et al., 2009; Ikeda et al., 2008), and CST-2 polymorphisms have been associated with human 
memory performance (Papassotiropoulos et al., 2006). In addition, CSTs dock vesicular 
cargo to kinesin-1, thereby determining the identity of transported cargo molecules (Araki et 
al., 2007; Konecna et al., 2006; Maruta et al., 2012; Vagnoni et al., 2011). More specifically, 
CST-1 mediates the transport of amyloid precursor protein (APP) via binding to X11/Mint 
and protects this protein from proteolytic processing during axonal transport (Suzuki et al., 
2006; Vagnoni et al., 2012). Intriguingly, several CST peptides have been frequently 
identified in the cerebrospinal fluid of Alzheimer’s disease (AD) patients (Ringman et al., 
2012; Yin et al., 2009), and CST-3 accumulates in dystrophic neurites surrounding 
Amyloid-β (Aβ) plaques (Uchida et al., 2013). Moreover, CST-1 regulates Aβ production 
through the regulation of APP transport at axons (Vagnoni et al., 2012). These data suggest 
that CST-associated molecular pathways might contribute to the pathogenic mechanisms 
underlying AD. However, the synaptic functions of CSTs have not been investigated.
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Here, we characterized the effects of CSTs on the structure and function of synapses in 
hippocampal and somatosensory cortical layer II/III neurons in vivo. CST-3 specifically 
induced presynaptic differentiation. The simultaneous knockdown of all three CSTs, but not 
a single CST isoform, decreased inhibitory synapse densities in cultured hippocampal 
neurons. Strikingly, CST-deficient neurons were morphologically smaller, and the neuronal 
phenotype was completely restored through the exogenous expression of full-length CST 
proteins. Furthermore, the frequency of miniature inhibitory, but not excitatory, postsynaptic 
currents was specifically reduced in CST-deficient cultured hippocampal and somatosensory 
cortical neurons. Moreover, we observed that CST-3 forms functional (but not physical) 
complexes with Nrxs. These data suggest that CST-3 is a synaptogenic adhesion molecule 
that forms functional complexes with Nrxs to regulate inhibitory synapse function.
RESULTS
Using heterologous synapse-formation assays with plasmid vectors expressing the entire 
extracellular region of cell-surface proteins exhibiting brain-specific expression (Table S1), 
we screened for novel synaptogenic molecules that induce presynaptic differentiation 
(Biederer and Scheiffele, 2007). The results revealed that LRRTMs, Slitrks, and TrkC act at 
the axons of cocultured neurons to specifically trigger presynaptic differentiation (Ko et al., 
2009a; Yim et al., 2013). In addition, the expression of CST-3 also showed synaptogenic 
activity.
CST-3 Triggers Presynaptic Differentiation
To determine the synaptic function(s) of CST-3, we first examined whether all three CSTs 
trigger presynaptic differentiation in heterologous synapse-formation assays using 
HEK293T cells expressing each CST protein. To maximize the cell surface expression of 
CST proteins, we generated plasmids for the expression of full extracellular fragments of 
CSTs. CST-3, but not CST-1 or CST-2, strongly induced synapsin clustering (Figures 1A 
and 1B). In parallel experiments, CALS, the Drosophila ortholog of mammalian CSTs, did 
not induce synaptic clustering (data not shown). Similar to NL-2 (positive control), CST-3 
induced the synaptic clustering of both the excitatory presynaptic marker VGLUT1 
(vesicular glutamate transport 1) and the inhibitory presynaptic marker GAD67 (glutamic 
acid decarboxylase, 67 kDa), but not the excitatory postsynaptic marker PSD-95 
(postsynaptic density, 95 kDa) (Figures 1A and 1B). These results suggest that CST-3 is a 
novel postsynaptogenic factor that induces presynaptic differentiation.
N-terminal Cadherin Repeats Are Essential for the Presynapse-inducing Activities of 
CST-3
CSTs possess two extracellular cadherin motifs (Cad repeats), a single LG/LNS domain, a 
transmembrane segment, and a short intracellular region comprising X11- and kinesin-
binding sites (Araki et al., 2003; Vogt et al., 2001). To determine the domains responsible 
for CST-3 synaptogenic activity, we performed heterologous synapse-formation assays 
using deletion constructs of CST-3 extracellular fragments (Figure 2A). Only CST-3 
mutants containing both Cad repeats exhibited full synaptogenic activity in heterologous 
synapse-formation assays (Figures 2B and 2C). Cadherin repeats typically mediate 
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extracellular Ca2+-dependent homophilic adhesion; thus, we examined whether CSTs 
mediate homo- or heterophilic adhesion between CST family members using cell-adhesion 
and cell surface-labeling assays (Figure S1). We observed that CSTs showed no homo- or 
heterophilic adhesion activities, suggesting the existence of unidentified presynaptic 
ligand(s) for CSTs.
CST-3 mRNA and Protein Expression Patterns
Previous Northern blot and in situ hybridization analyses of CSTs revealed that these 
proteins are located in postsynaptic membranes and are widely expressed in multiple brain 
regions (Hintsch et al., 2002; Vogt et al., 2001). Intriguingly, although CST-1 is enriched in 
axonal growth cone vesicles in the developing brain, this protein is restricted to the 
postsynaptic membranes of excitatory and inhibitory synapses (Konecna et al., 2006; Vogt 
et al., 2001). To determine whether other CST isoforms are also expressed in the developing 
brain, we performed in situ hybridization using mouse brain sections obtained from various 
embryonic and postnatal developmental stages (Figure 3A). CST-1 mRNA was expressed 
through the entire body, and more abundantly in the central nervous system (Figure 3A), 
consistent with the previously reported CST-1 expression pattern (Vogt et al., 2001). In 
contrast, the distribution of CST-2 and CST-3 in E16-E18 mice was restricted to the central 
nervous system. In adult mouse brains, a strong CST-3 mRNA signal was observed in 
various brain areas, whereas CST-2 mRNA was locally distributed to brain regions, 
including the hippocampus and olfactory bulb (Figure 3A).
To confirm the results obtained in the in situ hybridization analysis, we generated CST 
polyclonal CST-1/CST-2 antibodies (pan-antibody, JK010) and a CST-3-specific antibody 
(JK001) (Figures 3B and 3C). The CST-3 antibody (JK001) was used to confirm the 
authenticity of the immunoreactive signals using CST-3-knockout mouse lysates (Figure 
3D). The expression of CST-1/CST-2 proteins abruptly increased between postnatal day 7 
(P7) and P14, whereas CST-3 protein was steadily expressed throughout the postnatal 
development of mouse brains (Figure 3E). However, these antibodies were not suitable for 
immunocytochemistry; thus, we were unable to determine the synaptic localization of CSTs 
in cultured neurons (data not shown). All three CST proteins were significantly expressed 
(although not clearly enriched) in the PSD fraction (Figure 3F), consistent with previously 
reported biochemical data (Vogt et al., 2001). Taken together, these results indicate that 
CST-3 is a PSD-localized synaptogenic adhesion molecule.
The Simultaneous Knockdown of All Three CSTs Decreases Inhibitory Synapse Density in 
Cultured Neurons
To determine whether CSTs are required for the maintenance of synapse structure, we 
generated a series of knockdown (KD) lentiviral vectors expressing short hairpin RNA 
(shRNA) targeting individual CSTs. Subsequently, we infected cultured mouse cortical 
neurons with these vectors, and assessed the endogenous target mRNA and protein levels 
using quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) and 
quantitative immunoblotting, respectively (Figures 4A and 4B). The shRNA suppressed 
endogenous mRNA expression ~90% for CST-1, ~80% for CST-2, and ~85% for CST-3 
(Figure 4B). We next investigated whether the single KD of CST-1, CST-2, or CST-3 
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altered the synapse number in cultured mouse hippocampal neurons. To this end, we 
infected cultured neurons at DIV3 with lentiviruses expressing only EGFP (Control) or co-
expressed EGFP with shRNAs against CST-1 (J73), CST-2 (J76), or CST-3 (J81). In 
addition, we immunostained neurons at DIV14 for synapsin and MAP2 to visualize the 
entire somatodendritic architecture of the infected neurons (Figure S2A). We observed that 
single KD of each CST did not alter synapse density, synapse size, synapse strength or soma 
size (Figures S2B–S2E), suggesting that either CSTs are not required for synapse 
maintenance or that CSTs are functionally redundant. To examine the potential functional 
redundancy of CSTs, we generated a triple-KD vector (CST-TKD) containing three human 
polymerase III promoters to drive the expression of shRNAs against all three CSTs and a 
ubiquitin promoter to drive expression of EGFP, facilitating the visualization of infected or 
transfected neurons (Figure 4A).
Using the CST-TKD vector, which successfully suppressed the mRNA levels of all three 
CSTs (Figure 4C), we examined whether CSTs are functionally redundant and essential for 
synapse maintenance in cultured hippocampal neurons (Figures 4 and S3). Strikingly, CST-
TKD significantly decreased the number of inhibitory synapses, assessed using inhibitory 
synaptic markers (GAD67 and gephyrin) (Figures 4D, 4E and S3). CST-TKD also 
significantly reduced the number of excitatory presynaptic puncta (labeled by VGLUT1), 
but not excitatory postsynaptic puncta (labeled by Homer1) (Figures 4D, 4E and S3). These 
data suggest that CST-TKD preferentially alters inhibitory, but not excitatory, synapse 
structure in cultured hippocampal neurons. As previously reported, an LRRTM1 and 
LRRTM2 double-KD vector (LRRTM-DKD) did not alter the synapse density (Figures 4D 
and 4E; (Ko et al., 2011)). We also transfected cultured neurons at DIV8 with CST-TKD or 
an empty lentiviral shRNA vector (Control) and immunostained neurons at DIV14 for 
synapsin and EGFP (Figure S4). The introduction of the CST-TKD vector induced a modest 
but significant decrease in synapse number without changing synapse or soma size, or any 
spine parameters (number, width or length) (Figures S4A–S4G). Taken together, these 
results suggest that CSTs redundantly maintain synapses in cultured hippocampal neurons.
KD of CSTs Decreases the Soma Size of Cultured Hippocampal Neurons
An analysis of cultured mouse neurons infected with CST-TKD lentiviruses showed a 
dramatic reduction in the soma size of CST-TKD-infected neurons compared with control or 
LRRTM-DKD-infected neurons (Figures 4D and 4F). Moreover, electrophysiology 
recordings in cultured hippocampal neurons revealed that CST-TKD caused a significant 
decrease in membrane capacitance (Cm) and a concomitant increase in input resistance (Rm) 
(Figures S5A and S5B). These results imply that CSTs might stimulate the development of 
hippocampal neurons during the early stages of development. To examine this hypothesis, 
we infected hippocampal neurons with Control or CST-TKD viruses at DIV3 and measured 
neuron soma size during cultured neuron development every other day from DIV5 to DIV13 
(Figures S6). We observed that the soma size of cultured neurons infected with control 
viruses abruptly increased between DIV7 and DIV9, whereas no increase in the soma size of 
neurons infected with CST-TKD was observed (Figures S6), suggesting that a deficiency of 
CST proteins arrests neuronal development, which manifests as an absence of growth in the 
cell body size. In contrast, the soma size of neurons transfected with CST-TKD was 
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unchanged (Figures S4D), indicating that the effects of CSTs in regulating neuronal soma 
size were non-cell-autonomous. Because the simultaneous KD of multiple proteins 
occasionally leads to confounding, non-specific phenotypes, we further examined whether 
the decreases in soma size and synapse number induced through CST-TKD could be rescued 
through the co-expression of shRNA-resistant CSTs (Figures 4G, 4H and 4I). We observed 
that superinfection with both CST-1 and CST-3 completely eliminated the deficits in both 
soma size and synapse density observed with CST-TKD (Figures 4G, 4H and 4I). Strikingly, 
the super-infection of either CST-1 or CST-3 alone did not restore the deficits in soma size, 
but did restore the deficits in synapse number, suggesting that all three CSTs contribute to 
the growth of the neuronal cell body in a concerted manner. We also noted that the lentiviral 
expression of CST-1, CST-2, or CST-3 alone did not affect synapse density (Figure 4H). 
Thus, we considered whether our lentiviral expression system yielded lower expression 
levels of CSTs than chemical transfection. Thus, we compared the effect of expressing 
CST-3 in cultured hippocampal neurons using a CST-3 lentiviral construct with CST-3 
expression plasmid transfection using a Ca2+-phosphate/DNA coprecipitation method 
(Figures S7A, S7B and S7C). The overexpression of CST-3 by chemical transfection 
significantly increased the synapse density, whereas lentiviral CST-3 expression did not, 
implying that the CST-3 expression level per se is critical for synapse maintenance (Figures 
S7A, S7B and S7C). Using the CST-3 WT expression vector, we found that CST-3 WT 
exerted synaptogenic activities in gain-of-function assays. CSTs are cleaved by α-secretases 
(Maruta et al., 2012), raising questions concerning the expression of these CST constructs 
on the surface of heterologous cells and neurons. We found that, although the majority of 
CSTs are secreted into the cell culture medium, 10–35% of CSTs are expressed on the 
surface of both HEK293T cells and cultured neurons (Figures S7D, S7E, S7F, S7G and data 
not shown), suggesting that surface-exposed CSTs remain competent.
KD of CSTs Leads to a Reduction in Inhibitory, but Not Excitatory, Synaptic Transmission 
In Vitro and In Vivo
To determine whether the changes in anatomical synapse numbers presented in Figure 4 
reflect changes in the number of functional synapses, we examined synaptic transmission in 
mouse cultured hippocampal neurons infected with control or CST-TKD viruses (Figures 
S5C–S5H). Strikingly, measurements of miniature excitatory postsynaptic currents 
(mEPSCs) showed that CST-TKD did not alter excitatory synaptic transmission (Figures 
S5C and S5E-S5F). In contrast, CST-TKD caused a significant decrease in the frequency, 
but not the amplitude, of miniature inhibitory postsynaptic currents (mIPSCs) (Figures S5D 
and S5G–S5H). These results suggest that, although CSTs are required for the maintenance 
of both excitatory and inhibitory synapses, these molecules are predominantly involved in 
regulating inhibitory synaptic functions.
To further corroborate the in vitro electrophysiological results, we examined the effect of 
CSTs KD in somatosensory cortical layer II/III neurons in vivo through the in utero 
electroporation at E15 and analysis at P14–19 (Figure 5A). Similar to the results obtained 
with cultured neurons, CST-TKD specifically reduced the frequency of mIPSCs (Figures 
5B, 5C and 5D) without altering the frequency or amplitude of mEPSCs (Figures 5E, 5F and 
5G). Unexpectedly, CST-TKD increased the amplitude of mIPSCs. The explanation for this 
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observation is not clear, but might reflect the increased soma size of CST-deficient neurons 
or increased gephyrin puncta intensity (see Figures 5J and 5K; see also Figure 4; data not 
shown). We detected no changes in the paired-pulse ratio (PPR) of inhibitory IPSCs in CST-
TKD neurons, indicating no effects on presynaptic functions (Figures 5H and 5I). Consistent 
with the cultured neuron morphology, the soma sizes of CST-TKD neurons were smaller, as 
demonstrated by a decrease in membrane capacitance and a trend toward increased input 
resistance (Figures 5J and 5K). Taken together, these results indicate that CSTs are required 
for inhibitory synaptic transmission in vitro and in vivo.
CST-3 Forms Functional Complexes with Nrxs to Induce Presynapse Development
CSTs contain two extracellular cadherin-repeats and an LNS domain, and CST-3 displays 
synaptogenic activity, inducing presynaptic differentiation in heterologous synapse-
formation assays (Figures 1 and 2). To identify proteins that interact with the extracellular 
regions of CST-3, we used affinity chromatography, employing recombinant CST-3 fusion 
proteins expressed from HEK293T cells transfected with Ig-CST-3 comprising the entire 
extracellular sequence of CST-3 fused to the Fc-domain of human IgG to probe solubilized 
mouse brains (Figure 6A). Mass spectrometry analyses of Coomassie Blue-stained gels 
revealed multiple bands that were not observed in the negative control lane (IgC; Figure 
6B). Among the identified peptides, multiple peptides were derived from cell surface 
proteins, such as Nrxs (Figures 6C, 6D, 6E, 6F, Table 1 and Table S2). We asked whether 
Nrxs are required for the synaptogenic activities of CST-3. We infected cultured neurons 
with lentiviruses expressing either an empty shRNA vector (Control) or a triple KD shRNA 
construct for Nrxs (Nrx-TKD). Subsequently, we performed heterologous synapse-
formation assays using infected neurons and HEK293T cells expressing CST-3, neuroligin-1 
(NL1; positive control) or Slitrk1 (negative control) (Figures 6G and 6H). Upon Nrx-TKD, 
we observed the absence of CST-3 induced synapsin clustering on contacting axons of co-
cultured hippocampal neurons. In parallel experiments, Nrx-TKD abolished the 
synaptogenic activities of NL1 but not those of Slitrk1, consistent with the notion that Nrxs 
are presynaptic receptors for NL1 (note that PTPδ and PTPσ are presynaptic ligands for 
Slitrk1; see (Gokce and Sudhof, 2013; Yim et al., 2013)). Taken together, these results 
indicate that CST-3 forms a functional complex with Nrxs.
CST-3 Does Not Directly Interact with Nrxs
The fact that presynaptic Nrxs are functional receptors for CST-3 (Figure 6) prompted us to 
examine whether Nrxs directly bind to CST-3. First, we employed cell surface-labeling 
assays to determine whether CST-3 directly binds to both α- and β-Nrxs (Figures 7A and 
7B). We examined the binding of recombinant Ig-fusion proteins of Nrx-1α and −1β lacking 
an insert in splice site #4 (Ig-Nrx1αSS4− and Ig-Nrx1βSS4−, respectively) to HEK293T cells 
expressing HA-tagged CSTs. Surprisingly, we observed no binding of the Ig-Nrx1 fusion 
proteins with HA-CSTs in cell surface-labeling assays (Figure 7A). Consistent with this 
observation, we found that the Ig-CST-3 fusion protein did not bind FLAG-tagged Nrxs in 
cell surface-labeling assays (Figure 7B). There are three alternative splicing sites unique to 
α-Nrxs (Ullrich et al., 1995); thus we hypothesized that the presence of inserts at any or all 
of these sites (SS#1, SS#2, and SS#3) might modulate the binding between CST-3 and α-
Nrxs in a combinatorial manner. To examine this hypothesis, we generated a series of 
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Nrx-1α constructs containing a subset of domains with selected splice variants (see Figure 
7C for schematic diagrams of HA-Nrx-1α constructs) and analyzed the binding of these 
proteins to recombinant CST-3 using cell surface-labeling assays (Figure 7D). Strikingly, 
any Nrx1α variants showed no robust binding to HA-CST-3, indicating that Nrx-1α is not a 
direct ligand for CST-3. Moreover, neither Nrx-2α nor Nrx-3α interacted with CST-3 in cell 
surface-labeling assays (Figure 7D). Consistently, we found that CST-3 Cad did not bind to 
Nrx1α, suggesting that CST-3 exerts synaptogenic activity through a mechanism 
independent of direct binding to Nrxs (Figure 7A). Furthermore, pull-down experiments 
using immobilized Nrx-1α and Nrx-1β (Ig-Nrx-1αSS4− and Ig-Nrx-1βSS4−) Ig-fusion 
proteins with mouse synaptosomal fractions revealed that both Ig-Nrx-1αSS4− and Ig-
Nrx-1βSS4− effectively captured NL1, but did not bind to CSTs (Figure 7E), supporting the 
absence of an interaction of Nrx with CSTs. Viewed together, these results suggest that 
CST-3 requires Nrxs for its presynapse-inducing activities but is indirectly linked to them.
DISCUSSION
Currently, the neural roles of CST-1 have been extensively studied in the brain, showing that 
CST-1 is localized to both excitatory and inhibitory synapses and forms a tripartite complex 
with both Mint/X11 adaptor protein and APP, stabilizing intracellular APP metabolism and 
thereby suppressing Mint/X11-mediated Aβ-secretion (Araki et al., 2003; Vogt et al., 2001). 
Moreover, CST-1 mediates the transport of axonal APP-containing organelles in a 
kinesin-1-dependent manner (Konecna et al., 2006; Vagnoni et al., 2012; Vagnoni et al., 
2011). Recently, several genetic studies have implicated CST-2 polymorphisms in episodic 
memory performance, suggesting that CST-2 might regulate cognitive processes in the brain 
(Papassotiropoulos et al., 2006; Preuschhof et al., 2010). However, the synaptic functions of 
CST proteins have not been investigated. Particularly, the functions of CST-3 have been less 
explored than those of CST-1 and CST-2. The cadherin superfamily proteins are key 
regulators of various neuronal processes, but have been generally considered dispensable for 
de novo synapse formation (Scheiffele et al., 2000; Takeichi, 2007). Instead, these proteins 
have been suggested as critical for modulating numerous synaptic signaling pathways and 
synaptic plasticity (Arikkath and Reichardt, 2008). Here, we demonstrated that the two 
cadherin repeats of CST-3 are required for the synaptogenic activity of this protein (Figure 
2). However, it was recently reported that the cadherin repeats of CST-3 are required, but 
not sufficient, for the synaptogenic activity of CST-3 (Pettem et al., 2013), inconsistent with 
the results obtained in the present study. Although the nature of this discrepancy is currently 
unclear, the surface expression levels of the plasmids used in these two studies might differ, 
leading to completely different conclusions. Moreover, the fact that CSTs possess only two 
cadherin repeats at the N-terminus is a striking exception in the cadherin superfamily, as the 
majority of cadherin proteins possess five or more repeats (Hulpiau and van Roy, 2009). 
Furthermore, CST-TKD halted neuron growth, resulting in smaller soma size (Figures 4 and 
S6). Although the roles of cadherin superfamily proteins in neuron development have been 
relatively well established, to our knowledge, this study is the first report that members of 
this family are directly involved in the neuron soma development. Importantly, CSTs are 
among a small group of evolutionarily conserved synapse organizers, including NLs, Nrxs, 
and Leukocyte antigen-related receptor protein tyrosine phosphatases (LAR-RPTPs). In 
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invertebrates, these synapse organizers have been implicated in neuron development and 
synaptic functions (Calahorro and Ruiz-Rubio, 2013; Hu et al., 2012). CASY-1, the C. 
elegans ortholog of CSTs, is also essential for associative learning (Hoerndli et al., 2009; 
Ikeda et al., 2008); the Drosophila ortholog of CSTs (Cals) has not yet been functionally 
explored. Because the neuronal expression of human CST-2 in C. elegans functionally 
rescues the learning defects of CASY-1 mutants, we also examined whether Cals is 
synaptogenic using heterologous synapse-formation assays. However, Cals proteins, such as 
CST-1 or CST-2, did not induce presynaptic differentiation (data not shown). Thus, 
whether the functional significance of the Nrx/CST interaction reported in the present study 
also applies to the other model organisms remains undetermined.
Nrxs are essential for synapse formation and function (reviewed in Craig and Kang, 2007; 
Sudhof, 2008). The coupling of calcium channels to presynaptic machinery in mouse 
genetics studies has shown that α-Nrxs are important for presynaptic functions, but not 
structural integrity (Dudanova et al., 2007; Missler et al., 2003). The loss of all three α-Nrxs 
dramatically reduces spontaneous and evoked synaptic transmission at both excitatory and 
inhibitory synapses, although the defect in excitatory synaptic transmission reflects an Nrx-
α1 deficiency (Etherton et al., 2009; Missler et al., 2003). α-Nrxs trans-synaptically 
interacts with a multitude of postsynaptic adhesion molecules, including NLs, LRRTMs, 
cerebellins, dystroglycans, latrophilins, and neurexophilins (reviewed in (Krueger et al., 
2012)). However, because most of these postsynaptic ligands interact with both α- and β-
Nrxs (except neurexophilins), the functions of these synaptic adhesion pathways cannot be 
exclusively attributed to α-Nrx-specific synaptic functions. The data obtained in the present 
study suggest that CST-3 does not form a physical complex with Nrxs, but requires 
interactions with these molecules for synaptogenic activities, suggesting unidentified 
‘intermediary’ proteins that bridge CST-3 and Nrxs. A recent study reported that α-Nrxs, but 
not β-Nrxs, directly interact with CST-3 (Pettem et al., 2013). These authors presented a 
series of cell surface-labeling and pull-down assays to demonstrate the interaction of CST-3 
with α-Nrxs. However, we did not observe any significant binding of CST-3 to any of the 
three α-Nrxs in cell surface-labeling assays (Figure 7). Moreover, we found that various 
deletion variants of Nrx-1α did not interact with CST-3. Furthermore, we did not observe 
any significant enrichment of CSTs with recombinant Nrx-1α proteins in mouse brain pull-
down assays (Figure 7). Overall, we found no clear-cut evidence to support the direct 
interaction of CST-3 with α-Nrxs. Nevertheless, we observed that Nrxs are essential for 
CST-3 function because the triple-knockdown of Nrxs significantly reduced the 
synaptogenic activities of CST-3 (Figure 6). Currently, there is no precise explanation for 
the discrepant results between the two papers. Indeed, our data present two inherent 
paradoxes that we cannot at present resolve, but that paint a very different picture than that 
proposed by Pettem et al. First, in artificial synapse-formation assays only CST-3 is active, 
but not the other CSTs, whereas only a combined triple knockdown of all CSTs affects 
synapse density. Second, in pull-downs with recombinant CST-3 some Nrxs were found and 
in artificial synapse-formation assays the presynaptic Nrx-TKD blocked CST-3-induced 
synapse formation, but in all other binding assays, no CST-3 binding to Nrxs was detected. 
Most of these data were obtained in our laboratories before the Pettem et al. was published 
but we did not proceed to publication because we could not rationally reconcile these results 
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and formulate a coherent conclusion from them. We do feel, however, that based on our 
observations it is highly unlikely that CSTs are general Nrx ligands analogous to LRRTMs, 
neuroligins, or cerebellins.
In the present study, we found that the suppression of multiple CST isoforms, but not 
individual CSTs, reduced synapse density, suggesting redundancy among CST isoforms 
(Figure 4). However, electrophysiology experiments in both cultured and in vivo neurons 
indicated that CSTs act preferentially to inhibitory synapse structure and function (Figures 5 
and S5). These results are consistent with those from previous reports, showing that triple 
NL loss through acute KD in cultured neurons suppresses the frequency of mIPSCs (Chih et 
al., 2005). Moreover, α-Nrx-specific sequences confer specific activity toward inhibitory 
synapses in heterologous synapse formation-assays (Kang et al., 2008), suggesting that 
CST-3 might be a major postsynaptic mediator of inhibitory synapse organization through 
α-Nrxs. Notably, although CST-3 KD alone did not significantly affect synapse density in 
cultured neurons (Figure 4), synaptic transmission might be impaired at specific synapses, as 
demonstrated for individual NL isoforms (Chubykin et al., 2007). Consistently, analyses of 
CST-3-KO mice showed that both excitatory and inhibitory synaptic transmission are 
impaired (Pettem et al., 2013).
Although certain mechanistic details remain unresolved, CSTs have been predominantly 
associated with AD pathogenesis (reviewed in (Suzuki et al., 2006)). For example, CST-1 
modulates the effects of APP processing and trafficking, and CSTs co-accumulate with APP 
in dystrophic neuritis. Moreover, CST-1 KD perturbs the axonal transport of APP-
containing vesicles and alters APP processing, leading to increased Aβ production (Vagnoni 
et al., 2012). Furthermore, the proteolytically processed C-terminal fragment of CST-3 
(CTF) accumulates in dystrophic neurites surrounding Aβ plaques in AD model mice, 
accelerating neuronal death (Uchida et al., 2013). Intriguingly, CST-1 and CST-3 have been 
identified as potential biomarkers of AD (Ringman et al., 2012; Yin et al., 2009). Recently, 
several γ-secretase mutations impair Nrx-3β processing, linking Nrxs with AD pathogenesis 
(Bot et al., 2011). It is tempting to speculate that the misregulation of CST-3 and/or Nrx 
proteolytic processing might induce a subset of early-onset familial AD. It has been 
suggested that an imbalance between excitatory and inhibitory synapses is the central 
mechanism underlying a multitude of neuropsychiatric disorders. In the present study, we 
observed that inhibitory synapse function is selectively disrupted through CST-TKD in both 
cultured and in vivo neurons. Although there are currently no reports that CSTs are involved 
in neuropsychiatric disorders, it is likely that the synaptic dysfunction of CSTs contributes to 
the pathogenesis of multiple neuropsychiatric disorders. Intriguingly, CST-1 mRNA levels 
are upregulated in chronic cocaine-treated mice, suggesting that CST-1 dysfunction might 
be associated with addiction (Yao et al., 2004) via impaired long-term synaptic plasticity at 
inhibitory synapses (Niehaus et al., 2010). Some neuropsychiatric disorders (e.g., 
schizophrenia, autism, and intellectual disabilities) has been associated with specific defects 
in the development and function of interneurons. Considering that CST-2 and CST-3 are 
highly expressed in interneurons (Hintsch et al., 2002), it is possible that the molecular 
dysfunctions of these CST isoforms contribute to these diseases.
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In conclusion, we identified CST-3 as a synaptogenic adhesion molecule that forms 
complexes with Nrxs. Future studies should identify ‘intermediary’ protein(s) that 
functionally bridge CST-3 and Nrxs, characterize the detailed molecular mechanisms 
underlying the intracellular transduction of CST-3/Nrxs extracellular signals, identify the 
presynaptic receptors for CST-1 and/or CST-2 to establish a complete understanding of the 
synaptic functions of CST proteins, and validate the functions of CSTs proposed in the 
current study in vivo.
EXPERIMENTAL PROCEDURES
The Construction of Expression Vectors
HA-CSTs encode full-length mouse CSTs containing an inserted HA-epitope. The signal 
peptide sequence of CST-1 (amino acids [aa] 1–28) was initially PCR-amplified, digested 
with HindIII/BglII, and cloned into the GW1 vector (British Biotechnology). The remaining 
of CST-1 sequences (aa 29–979) were PCR-amplified, digested with BglII and EcoRI, and 
cloned into the GW1 vector. Full-length CST-2 and CST-3, excluding the corresponding 
signal peptide sequences (CST-2, aa 21–966; CST-3, aa 20–956), were PCR-amplified, 
digested with XmaI and SacII, and subcloned into the pDisplay vector (Invitrogen). pDis-
CST-3 deletion variants encode the indicated CST-3 fragment (Cad+LNS, aa 36–541; LNS
+linker, aa 335–846; Cad repeats, aa 20–257; LNS, aa 335–541; Cad repeat 1, aa 36–158; 
and Cad repeat 2, aa 152–259) cloned into the pDisplay vector at XmaI and SacII sites. 
pDis-Nrxs encode the indicated Nrx-1α, Nrx-1β, Nrx-2α, or Nrx-3α fragments cloned into 
the pDisplay vector at the indicated restriction enzyme sites. To construct shRNA lentiviral 
expression vectors, oligonucleotides targeting mouse CST-1, CST-2, or CST-3 were 
annealed, phosphorylated, and cloned into the XhoI and XbaI sites of a single KD vector 
(L-309 vector; see Figure 4A for a schematic diagram of vectors) immediately downstream 
of the human H1 promoter. For CST-TKD, oligonucleotides targeting CST-1 (J73), CST-2 
(J76), and CST-3 (J81) were subcloned respectively into the XhoI-XbaI (J73), BstEII-BsiWI 
(J76), and SbfI-BstBI (J81) sites of a TKD vector (L-313 vector) containing two human H1 
promoters and two human U6 promoters. For the details, see Extended Experimental 
Procedures.
Antibodies
used in this study are described in detail in the Supplemental materials associated with this 
paper.
Heterologous Synapse-formation Assays, Cell Surface-labeling Assays, and Cell-adhesion 
Assays
were performed using HEK293T cells as previously described (Ko et al., 2009a)
Affinity Chromatography and Mass Spectroscopy
were performed using recombinant CST-3 fusion proteins as previously described (Ko et al., 
2009a).
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Production of Recombinant Lentiviruses
Recombinant lentiviruses were produced through the transfection of human embryonic 
kidney 293T cells with four plasmids—L-313 vectors (L-313-Nrx-TKD or L-313 alone), 
pRRE, pVSVg, and pREV—using FuGENE-6 (Roche) as previously described (Ko et al., 
2011).
Primary Neuronal Culture, Transfections, Immunocytochemistry, Image Acquisition and 
Analyses
were performed using E18-derived mouse hippocampal cultured neurons and confocal 
microscopy as previously described (Ko et al., 2009b).
In Utero Electroporation
Pregnant ICR mice at 15 days post coitum (d.p.c) were anesthetized with an intraperitoneal 
injection of pentobarbital sodium, and the uterine horns were exposed through a longitudinal 
incision in the abdomen. Approximately 1 µl of DNA solution containing 1 mg/ml 
pCAGGS-EGFP, 1.5 mg/ml L-315-CST-TKD shRNA, and 0.01% Fast Green in PBS or 1 
mg/ml pCAGGS-EGFP, 1.5 mg/ml L-315 control shRNA, and 0.01% Fast Green in PBS, 
was injected into the lateral ventricle of each embryo through a glass capillary electrode. 
The uteri were returned to the peritoneal cavity, and the incisions were sutured. The 
operated mice were returned to their home cages and subsequently allowed to deliver 
naturally. The transfected pups were identified at P0 by visualizing the GFP signals through 
the scalp using an LED penlight (Handy Blue; Reryon).
Electrophysiology
Cell culture and slice electrophysiology were performed as previously described (Ko et al., 
2011).
Statistics
All data are expressed as the means ± SEM. All experiments were performed with at least 
three independent cultures and statistically evaluated using Student’s t-test and one-way 
ANOVA, with cell numbers as the basis for ‘n’.
Further details available in the Extended Experimental Procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• CST-3 specifically induces presynaptic differentiation
• CSTs are required for inhibitory synapse structure and function
• CST-3 requires Nrxs as functional receptors for presynaptic development
• CST-3 does not directly interact with Nrxs
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Figure 1. CST-3 Induces Presynaptic Differentiation in Heterologous Synapse-formation Assays
(A) CST-3 promotes the formation of excitatory and inhibitory presynapses in heterologous 
synapse-formation assays. Rat hippocampal neurons were cocultured for 3 d (DIV10-13) 
with HEK293T cells expressing EGFP alone (control) or coexpressing EGFP and N-
terminally HA-tagged CST-1 extracellular fragment (CST-1), CST-2 extracellular fragment 
(CST-2), CST-3 extracellular fragment (CST-3), or an mVenus-fusion protein of 
neuroligin-2 (NL2). The panels show representative immunofluorescence images of 
cocultures stained with antibodies to EGFP (green) and various presynaptic (VGLUT1, 
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GAD67) and postsynaptic (PSD-95) markers (red). Coincident green and red signals are 
shown in yellow. Scale bar = 20 µm (applies to all images).(B) Quantitation of the 
heterologous synapse-formation activity of CST-1, CST-2, CST-3, and NL2. To quantify the 
experiments described in (A), the ratio of the synaptic marker staining to EGFP fluorescence 
(from absolute red and green fluorescence values) was measured. All data are shown as 
means ± SEMs (3*p<0.001, assessed using analysis of variance [ANOVA] with Tukey’s 
test; “n” denotes the total number of HEK293T cells analyzed, as follows: Control/synapsin, 
n=18; CST-1/synapsin, n=21; CST-2/synapsin, n=17; CST-3/synapsin, n=16; NL2/synapsin, 
n=14; Control/VGLUT1, n=22; CST-1/VGLUT1, n=17; CST-2/VGLUT1, n=15; CST-3/
VGLUT1, n=15; NL2/VGLUT1, n=16; Control/GAD67, n=15; CST-1/GAD67, n=15; 
CST-2/GAD67, n=14; CST-3/GAD67, n=15; NL2/GAD67, n=14; Control/PSD-95, n=15; 
CST-1/PSD-95, n=16; CST-2/PSD-95, n=17; CST-3/PSD-95, n=16; and NL2/PSD-95, 
n=15).
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Figure 2. N-terminal Cadherin Repeats Are Required for the Synaptogenic Activities of CST-3
(A) Diagrams of the CST-3 variants used in heterologous synapse-formation assays. The full 
extracellular region of CST-3 (Ecto-full) carrying an HA epitope inserted after the signal 
peptide sequence was cloned into the pDisplay vector. CST-3 fragments carrying the 
following extracellular regions were also prepared as pDisplay vectors: Cad+LNS, a CST-3 
fragment containing cadherin repeats and an LNS domain; LNS+linker, a CST-3 fragment 
containing the LNS domain and the linker region between an LNS domain and a 
transmembrane segment; Cad repeats, a CST-3 fragment containing two cadherin repeats; 
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LNS, a CST-3 fragment containing the LNS domain; Cad repeat 1, a CST-3 fragment 
containing the first cadherin repeat; and Cad repeat 2, a CST-3 fragment containing the 
second cadherin repeat. (B–C) Synaptogenic activity of various CST-3 constructs (described 
in [A]) in heterologous synapse formation-assays. Representative immunofluorescence 
images of cocultures stained with antibodies to HA (green) and synapsin (red). Coincident 
signals are shown in yellow. Scale bar = 20 µm (applies to all images) (B). Quantitation of 
heterologous synapse-formation assays (C), measured as the ratio of synapsin to HA 
fluorescence signals. The dashed lines correspond to Control values, used as the baseline. 
The data are shown as the means ± SEMs (3*p<0.001, assessed using analysis of variance 
[ANOVA] with Tukey’s test; “n” denotes the total number of HEK293T cells analyzed, as 
follows: Control, n=15; Ecto-Full, n=17; Cad+LNS, n=17; LNS+linker, n=16; Cad repeats, 
n=14; LNS, n=15; Cad repeat 19, n=16; and Cad repeat 2, n=16).
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Figure 3. Expressions of CSTs in Mouse Brains
(A) CST mRNA distribution patterns in the developing and adult mouse brains. Sections 
from E16, E18, P7, P14, P21, and P48 (adult) mouse brains were probed with CST-1, 
CST-2, and CST-3 cRNAs. Scale bar = 5 mm. Cb, cerebellum; Ctx, cerebral cortex; Hc, 
hippocampus; OB, olfactory bulb. (B) Biochemical characterization of the CST antibodies 
used in this study. Immunoblot analyses of CST antibodies using mouse brain synaptosomes 
and lysates from HEK293T cells, untransfected or transfected with CST-2 or CST-3 
expression vector. JK010 is reactive to both CST-1 and CST-2 proteins, whereas JK001 is 
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specific to CST-3. Br., brain; P2, crude synaptosomes; Unt., untransfected HEK293T cell 
lysates. (C) Cross-reactivity of the CST antibodies. HEK293T cells, untransfected or 
transfected with the indicated CST expression vectors, were immunoblotted with anti-
CST-1/CST-2 (JK010) and anti-CST-3 (JK001) antibodies. The expression of HA-tagged 
CST vectors was confirmed through immunoblotting with anti-HA antibodies. An anti-α-
tubulin antibody was used for normalization. (D) Authenticity of the anti-CST-3 antibody 
(JK001). P2 fractions from brains of wild-type or CST-3-KO mice were subjected to 
immunoblot analyses with the indicated antibodies. An anti-α-tubulin antibody was used for 
normalization. (E) The expression of CST proteins during development. E, embryonic day; 
P, postnatal day. An anti-α-tubulin antibody was used for normalization. (F) Localization of 
CST proteins in PSD fractions. The proteins from each mouse brain fraction (5 µg) were 
subjected to immunoblotting with the indicated antibodies. P2, crude synaptosomal fraction; 
S2, cytosolic and light membrane fraction; PSD, postsynaptic density fraction; SynPhys, 
synaptophysin; Synapto. Fraction, Synaptosomal fraction.
Um et al. Page 22
Cell Rep. Author manuscript; available in PMC 2014 September 27.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Knockdown of All Three CSTs, but Not Individual CST Isoform Alone, Reduces 
Synapse Density and Soma Size in Cultured Neurons
(A) Schematic diagram of lentiviral shRNA vectors for KD of single CST isoforms (denoted 
CST-SKD) or triple KD of CST-1 to CST-3 (denoted CST-TKD). (B) KD efficacies of 
shRNA lentiviruses. Levels of target CST mRNAs (CST-1 to CST-3) were measured by 
quantitative RT-PCR in cultured mouse cortical neurons infected at DIV3 with lentiviruses 
expressing the indicated shRNAs. The mRNAs were prepared at DIV12-13. The dotted line 
represents the 75% KD cutoff level for tests of biological effects. (C) Measurements of 
target mRNA levels (CST-1, CST-2, and CST-3) in cultured cortical neurons as described in 
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(B), except that neurons were infected with CST-TKD lentiviruses expressing shRNAs 
targeting CST-1, CST-2, and CST-3 [described in (A)]. The target mRNA measured is 
colored coded as indicated on the upper right. Dotted line represents the 75% KD cutoff 
level for tests of biological effects. (D) Representative images of cultured hippocampal 
neurons infected at DIV3 with lentiviruses expressing EGFP alone (control); coexpressing 
EGFP with shRNAs against CST-1, CST-2, and CST-3 (CST-TKD); or coexpressing EGFP 
with shRNAs against LRRTM1 and LRRTM2 (LRRTM-DKD). Neurons were analyzed 
through double immunofluorescence labeling for MAP2 (blue) and synapsin (red) at DIV14. 
Scale bar = 35 µm (applies to all images). (E–F) Summary graphs of the effects of CST-
TKD in neurons on synapse density (E) (measured using synapsin as a general synapse 
marker, VGLUT1 as an excitatory presynaptic marker, GAD67 as an inhibitory presynaptic 
marker, Homer1 as an excitatory postsynaptic marker, and gephyrin as an inhibitory 
postsynaptic marker), and soma size (F) (measured using MAP2 signals). The data are 
shown as the means ± SEMs (3*p<0.001, assessed using analysis of variance [ANOVA] 
with Tukey’s test; 2–3 dendrites per transfected neuron were analyzed and group-averaged; 
“n” denotes the total number of neurons analyzed, as follows: Control/synapsin, n=16; CST-
TKD/synapsin, n=18; LRRTM-DKD/synapsin, n=15; Control/VGLUT1, n=15; CST-TKD/
VGLUT1, n=15; Control/GAD67, n=16; CST-TKD/GAD67, n=15; Control/Homer1, n=18; 
CST-TKD/Homer1, n=21; Control/Gephyrin, n=22; and CST-TKD/Gephyrin n=22). (G) 
Representative images of cultured hippocampal neurons infected with a vector expressing 
control lentiviruses (control); a vector expressing shRNA viruses against CST-1, CST-2, and 
CST-3 (CST-TKD); the CST-TKD vector together with lentiviruses expressing full-length 
human CST-1 [denoted as Rescue (+CST-1)], full-length human CST-3 [denoted as Rescue 
(+CST-3)], or both human CST-1 and human CST-3 [denoted as Rescue (+CST-1/3)]; or 
lentiviruses expressing only full-length human CST-1 (CST-1), full-length human CST-2 
(CST-2), or full-length human CST-3 (CST-3). The neurons were analyzed through double 
immunofluorescence using antibodies to MAP2 (blue) and synapsin (red) at DIV14. Scale 
bar = 35 µm (applies to all images). (H–I) Summary graphs of the effects of the indicated 
lentiviruses on synapse density (H) (measured using synapsin as a general synapse marker, 
and soma size (I) (measured using MAP2 signals). Note that lentiviral expression of CST-3 
did not increase synapse density, whereas high-level overexpression of CST-3 by calcium 
phosphate-mediated transfection significantly increased the synapse density (see Figure S7). 
The data are shown as the means ± SEMs (3*p<0.001, assessed using analysis of variance 
[ANOVA] with Tukey’s test; 2–3 dendrites per transfected neuron were analyzed and 
group-averaged; “n” denotes the total number of neurons analyzed, as follows: Control, 
n=19; CST-TKD, n=14; CST-TKD+CST-1 rescue, n=15; CST-TKD+CST-2 rescue, n=16; 
CST-TKD+CST-3 rescue, n=17; CST-TKD+CST-1/3 rescue, n=16; CST-1, n=15; CST-2, 
n=22; and CST-3, n=17).
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Figure 5. CST Knockdown Impairs Inhibitory, but Not Excitatory, Synaptic Transmission In 
Vivo
(A)In utero electroporation was performed at E15 to transfect neuron precursors with 
control or CST-TKD vectors. Coronal brain sections were prepared at P14-19. Many green 
fluorescence protein (GFP)-positive neurons were detected in layer I I/I II of somatosensory 
cortex. Scale bar = 250 µm. (B–D) Effect of CST proteins on inhibitory synaptic 
transmission. Representative traces (B) of mIPSCs in somatosensory cortical neurons in 
layer II/III electroporated in utero with control or CST-TKD vector. Summary graphs of the 
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frequencies (C) and amplitudes (D) of mIPSCs in neurons transfected with control or CST-
TKD vectors. (E–G) Effect of CST proteins on excitatory synaptic transmission. 
Representative traces (e) of mEPSCs in somatosensory cortical neurons in layer II/III 
electroporated in utero with control or CST-TKD vector. Summary graphs of the 
frequencies (F) and amplitudes (G) of mEPSCs in neurons transfected with control or CST-
TKD vectors. (H–I) Effect of CST proteins on PPR (amplitude of the second IPSC divided 
by that of the first). Representative traces (H) and summary graph (I) of PPR measured with 
100-ms interstimulus intervals are shown. (J–K) Membrane capacitance (j; Cm) and input 
resistance (k; Rm) measured in control and CST-TKD neurons. The data shown in the panels 
(B-K) represent the means ± SEMs (*p<0.05 using Student’s t-test; “n” denotes the total 
number of cells recorded, as follows: mIPSC control, n=10; mIPSC CST-TKD, n=12; 
mEPSC control, n=29; mEPSC CST-TKD, n=30; PPR control, n=13; and PPR CST-TKD, 
n=15).
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Figure 6. Nrxs Are Functional Receptors For CST-3 To Promote Presynaptic Development
(A) Coomassie Blue-stained gel of recombinant Ig-control (IgC), and Ig-CST-3 (Ig-CST-3) 
fusion proteins used for affinity chromatography and pull-down experiments. (B) 
Identification of specific CST-3-binding proteins in mouse brains. Solubilized mouse brain 
proteins were subjected to pull-down experiments with IgC or Ig-CST-3-fusion protein. 
Equivalent amounts of bound proteins were resolved using SDS-PAGE, and the gels were 
subsequently Coomassie Blue-stained. The boxed regions indicate the specific bands unique 
to the Ig-CST-3-bound fraction, which were further analyzed through mass spectroscopy. 
(C–D) Mass spectrometry data. Total ion chromatogram (XIC) of an LC separation from Ig-
CST3-bound eluates (C). Extracted ion chromatogram (EIC) of ion m/z 733.33 and 547.29 
from CST-3 (19.30 min) and Nrx-1α (25.77 min; D). (E–F) The MS/MS spectrum of two 
double-charged peptides unique for CST-3 and Nrx-1α obtained from LC-MS/MS at 733.33 
and 547.29, fragmented to produce an MS/MS spectrum with β- and ψ-ion series describing 
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the sequences ADESWQGTVTDTR (aa 684–696) and SADYVNLALK (aa 327–336). (G–
H) The effect of triple Nrx knockdown (sh-Nrx1/2/3) on the synaptogenic activities of 
CST-3, NL1, and Slitrk1. Representative immunofluorescence images (G) of cocultures 
stained with antibodies to mVenus or HA (green) and synapsin (red). Coincident signals are 
indicated in yellow. Scale bar = 10 µm (applies to all images). Quantitation (H) of 
heterologous synapse-formation assays, measured as the ratio of synapsin to mVenus/HA 
fluorescence signals. The dashed lines correspond to the Control values used as the baseline. 
The data are shown as the means ± SEMs (3*p<0.001 and *p<0.05 using analysis of 
variance [ANOVA] with Tukey’s test; “n” denotes the total number of HEK293T cells 
analyzed, as follows: Control/sh-control, n=19; Control/sh-Nrx1/2/3, n=45; CST-3/sh-
control, n=43; CST-3/sh-Nrx1/2/3, n=39; NL1/sh-control, n=30; NL1/sh-Nrx1/2/3, n=28; 
Slitrk1/sh-control, n=24; and Slitrk1/sh-Nrx1/2/3, n=29).
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Figure 7. Nrxs Do Not Directly Interact with CST-3
(A) Cell surface-labeling assays. HEK293T cells expressing NL1-mVenus (NL1), or HA-
tagged CSTs (CST-1, CST-2, CST-3, or CST-3 Cad) were incubated with control Ig-fusion 
proteins (Ig) or IgNrx-1α-1, or IgNrx-1β-1 (Ig-fusion proteins of neurexin-1α and −1β, 
respectively, lacking an insert in splice site #4). The cells were analyzed by 
immunofluorescence imaging for Ig-fusion proteins (red) and HA/mVenus (green). 
Representative merged images are shown. Scale bar = 10 µm (applies to all images). (B) 
Cell surface-labeling assays. HEK293T cells expressing pcDNA3-FLAG-Nrx vectors were 
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incubated with Ig, Ig-CST-3 proteins (Ig-CST-3) or Ig-neuroligin-2 (Ig-NL2). The cells 
were analyzed by immunofluorescence imaging for Ig-fusion proteins (red) and FLAG 
(green). The only representative merged images are shown. Scale bar = 10 µm (applies to all 
images). (C) Domain structures of α- and β-Nrxs (top) and identities of pDisplay-Nrx 
constructs used for binding studies (bottom). SP, signal peptide; LNS, Lamin G-domain 
repeats, neurexins, and sex hormone-binding globulin; E, EGF-like sequences; CHO, 
carbohydrate attachment site; T, transmembrane region; blue numbered arrows, positions of 
canonical alternative splice sites (Ullrich et al., 1995). “-” corresponds to the no-insert 
variant, “+” corresponds to the small insert, and “++” corresponds to the large insert (see 
(Sugita et al., 2001)). N.A., not applicable. (D) Cell surface-labeling assays. HEK293T cells 
expressing pDis-Nrx-α constructs were incubated with control Ig or Ig-CST-3. The cells 
were analyzed by immunofluorescence imaging for Ig-fusion proteins (red) and HA (green). 
Representative merged images are shown. Scale bar = 10 µm (applies to all images). (E) 
Pull-down assays in solubilized mouse synaptosomal fractions. The pull-down assays were 
performed using IgC (control), IgNrx-1α-1 or IgNrx-1β-1 recombinant proteins. Equivalent 
amounts of bound proteins were analyzed using the antibodies indicated on the right side of 
the panels (Input = 5% of total).
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Table 1
α-Nrx Proteins as CST-3 Complexes Identified Through LC-MS/MS
Accession No Gene name Protein description Mascot score Peptide matches
Q9CS84 Nrx-1α Neurexin-1α 130 59
Q63374 Nrx-2α Neurexin-2α 26 29
Q6P9K9 Nrx-3α Neurexin-3α 70 48
Accession numbers refer to the Uniprot/SwissProt database.
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